Core Alternative Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-85
Closed -$3K 454
2021
Q4
$3K Buy
85
+27
+47% +$879 ﹤0.01% 251
2021
Q3
$2K Sell
58
-22
-28% -$704 ﹤0.01% 98
2021
Q2
$2K Buy
+80
New +$2.63K ﹤0.01% 73

Other funds holding OGN

Core Alternative Capital's OGN Position: Q1 2022 in Review

Core Alternative Capital sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 85 shares — an estimated $3K sold.

Core Alternative Capital first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $3K in Q4 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

  • Core Alternative Capital reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
  • Core Alternative Capital sold 85 Organon & Co shares in Q1 2022, an estimated $3K.
  • Core Alternative Capital first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
  • Core Alternative Capital's Organon & Co position peaked at $3K in Q4 2021.
  • 818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Core Alternative Capital's 13F filing for Q1 2022, filed 10 May 2022.